Therapeutic options for cardiogenic shock.
Lewis
Geraint W
GW
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D016887:Cardiopulmonary Resuscitation; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy; D012770:Shock, Cardiogenic / Q000628:therapy*
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D004837:Epinephrine